Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.63
-0.07 (-1.23%)
Sep 2, 2026, 1:09 PM EDT - Market open
Taysha Gene Therapies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -149.63 | -109 | -89.3 | -111.57 | -166.01 | -174.52 |
Depreciation & Amortization | 1.17 | 1.15 | 1.25 | 1.37 | 1.17 | 0.49 |
Other Amortization | 0.15 | 0.15 | - | 0.87 | - | - |
Asset Writedown & Restructuring Costs | 3 | 3 | 4.84 | 4.57 | 37.67 | 9.75 |
Stock-Based Compensation | 18.17 | 13.3 | 13.1 | 7.91 | 18.04 | 18.18 |
Other Operating Activities | -2.12 | 3.69 | 1.35 | 41.85 | 2.22 | 0.39 |
Change in Accounts Payable | 1.77 | -0.15 | -2.92 | -2.3 | -7.8 | 14.49 |
Change in Unearned Revenue | -5.49 | -9.77 | -8.33 | -15.45 | 33.56 | - |
Change in Other Net Operating Assets | 0.79 | 4.56 | -1.21 | -0.27 | -7.24 | 14.17 |
Operating Cash Flow | -132.19 | -93.09 | -81.23 | -73.02 | -88.39 | -117.04 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.38 | -0.74 | -0.37 | -3.87 | -20.62 | -15.3 |
Sale (Purchase) of Intangibles | -3 | - | - | -3.5 | -4.25 | -6.25 |
Other Investing Activities | 0.06 | 0.13 | 0.01 | 0.02 | -0.06 | - |
Investing Cash Flow | -3.32 | -0.6 | -0.36 | -7.35 | -24.93 | -21.55 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 49.85 | - | 39.55 | - | 39.96 |
Total Debt Issued | 49.85 | 49.85 | - | 39.55 | - | 39.96 |
Long-Term Debt Repaid | - | -40.61 | - | -43 | - | - |
Total Debt Repaid | -40.61 | -40.61 | - | -43 | - | - |
Net Debt Issued (Repaid) | 9.24 | 9.24 | - | -3.45 | - | 39.96 |
Issuance of Common Stock | 266.71 | 265.69 | 76.87 | 140.86 | 53.5 | - |
Other Financing Activities | -0.23 | -0.34 | -0.19 | -1.02 | -1.4 | -0.87 |
Financing Cash Flow | 275.72 | 274.59 | 76.68 | 136.39 | 52.1 | 39.08 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 140.21 | 180.9 | -4.9 | 56.02 | -61.22 | -99.51 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -132.57 | -93.83 | -81.6 | -76.89 | -109.01 | -132.35 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2416.99% | -960.07% | -979.23% | -497.62% | -4356.88% | - |
Free Cash Flow Per Share | -0.37 | -0.29 | -0.33 | -0.66 | -2.48 | -3.52 |
Levered Free Cash Flow | -80.97 | -56.7 | -48.15 | -68.51 | -75.31 | -71.32 |
Unlevered Free Cash Flow | -81.09 | -56.81 | -48.09 | -66.25 | -72.94 | -70.43 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 5.7 | 5.4 | 5.28 | 4.95 | 2.78 | 0.64 |
Change in Working Capital | -2.92 | -5.37 | -12.47 | -18.01 | 18.52 | 28.67 |